Search results
Order by most recent / most popular / relevance
Results: 1-10 of 15
NASDAQ Biotechnology Index surpasses all-time high in 1Q13
- Shook Hardy & Bacon LLP
- -
- USA
- -
- May 16 2013
The NASDAQ Biotechnology Index reportedly rose in the first quarter of 2013 (1Q13) above levels last seen during the 2000 genomics bubble peakthe
Life Tech shareholder sues to stop $13.6 billion sale to Thermo Fisher
- Shook Hardy & Bacon LLP
- -
- USA
- -
- May 2 2013
According to a news source, Life Technologies shareholder Chang Choi has filed a lawsuit on behalf of a class of company shareholders alleging breach
Cincinnati investor closes $4.4 million fund to invest in startups
- Shook Hardy & Bacon LLP
- -
- USA
- -
- June 30 2011
Cincinnati-based CincyTech, a venture development company that invests in startup biotech, information technology and advanced manufacturing businesses, has announced the closing of a $4.4 million Fund II targeted for 10 to 12 new startups in southwest Ohio
Biotech investments rise in Q4 2012, but remain off for the year
- Shook Hardy & Bacon LLP
- -
- USA
- -
- January 24 2013
Pricewatershouse Coopers LLP has released its fourth quarter (Q4) and final 2012 venture capital investment reports and notes that "Biotechnology
New program to provide accelerated “speed-to-market” for medical device entrepreneurs
- Shook Hardy & Bacon LLP
- -
- USA
- -
- March 1 2012
The nonprofit Memphis Bioworks Foundation and Innova, a pre-seed, seed and early-stage investor, have announced a program designed to help entrepreneurs bring medical device products and companies to market
Court upholds drug profit sharing; pharma co. breached agreement to negotiate deal
- Shook Hardy & Bacon LLP
- -
- USA
- -
- June 7 2012
A Delaware court has issued a letter opinion finalizing its 2011 ruling requiring SIGA Technologies Inc. to share profits from its smallpox drug with PharmAthene, Inc. PharmAthene, Inc. v. SIGA Techs, Inc., No. 267-VCP (Del. Ch., decided May 31, 2012
Financial group analyzes M&A deals in biotech and medical device industries
- Shook Hardy & Bacon LLP
- -
- USA
- -
- June 16 2011
According to an SVP Financial Group report, contrary to conventional wisdom, biotech exits occur faster than device exits and have lower, but solid, multiples on invested capital
Indian officials to scrutinize pharmaceutical M&As
- Shook Hardy & Bacon LLP
- -
- India
- -
- October 20 2011
Indian ministry officials have apparently decided that foreign companies may continue to invest in new pharmaceutical industry projects but that foreign proposals for mergers and acquisitions in this sector will have to undergo enhanced scrutiny
Colorado life sciences industry benefits from increased VC investments in 2011
- Shook Hardy & Bacon LLP
- -
- USA
- -
- March 1 2012
A Boulder, Colorado-based company that tracks, analyzes and reports global bioscience venture capital investment activity has released a report on 2011 trends, finding an increase in funding and deals from 2010
Company secures $10 million in venture capital financing to improve DNA sequencing technology
- Shook Hardy & Bacon LLP
- -
- USA
- -
- September 22 2011
NABsys, Inc., a Rhode Island-based developer of electronic systems used for sequencing and analyzing single-molecule DNA, has reportedly raised $10 million in new venture capital funding, closing a Series C preferred stock financing round
Current Search
- Author - Madeleine McDonough
- Author - Patrick Henderson
- Author - Chris A. Johnson
- Firm Name - Shook Hardy & Bacon LLP
- Workarea - Corporate Finance/M&A